FARE - Food Allergy Research & Education Logo
FARE Blog February 16, 2022

Asking About Allergies: Eating Food That Could Kill, Part 2

In this second post of a two-part blog series, food allergy advocate and college senior John Kosner interviews two young people who’ve pursued food allergy treatment through oral immunotherapy, or OIT.

Guest post by John Kosner

Hi, I’m John Kosner. I’m currently a senior at the University of Illinois in Urbana-Champaign studying Molecular and Cellular Biology with a minor in English. I’m on the pre-med track and have an interest in disability studies. I’m allergic to milk, eggs, peanuts, tree nuts and sesame. 

I wanted to learn more about oral immunotherapy (OIT) to treat food allergies, so I did some research on the subject and summarized what I learned in Part 1. Then, I sat down with Ally Kalishman, a freshman at Penn State University, and Jacqueline See-Tho, a high school junior in Northern California, to ask about their personal experience with allergies and the decision to leap into OIT treatment. Here are those interviews

Asking About Allergies: Ally Kalishman’s Oral Immunotherapy Story

Ally participated in several rounds of single-allergen immunotherapy under the medical supervision of her allergist.

Asking About Allergies: Jacqueline See-Tho’s Oral Immunotherapy Story

Jacqueline received oral immunotherapy through a clinical trial at an academic food allergy center. She received multiple-allergen OIT combined with the injectable drug Xolair® (omalizumab), which targets IgE antibodies.

Want to learn more? In the first part of this two-part blog series, check out John's explanation of oral immunotherapy (OIT) to treat food allergy.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.